| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
16,466 |
13,646 |
$702K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
12,260 |
9,996 |
$385K |
| 99497 |
|
1,445 |
1,264 |
$60K |
| G0438 |
Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit |
638 |
569 |
$59K |
| 80305 |
|
7,974 |
6,949 |
$49K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,927 |
1,919 |
$38K |
| 99443 |
|
756 |
652 |
$29K |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
437 |
404 |
$23K |
| 99442 |
|
675 |
613 |
$17K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
323 |
278 |
$11K |
| 36415 |
Collection of venous blood by venipuncture |
4,519 |
3,986 |
$7K |
| G0446 |
Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes |
1,397 |
1,214 |
$6K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
681 |
597 |
$5K |
| 99407 |
|
449 |
388 |
$5K |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
1,418 |
1,230 |
$4K |
| 96160 |
|
460 |
395 |
$3K |
| 99384 |
|
26 |
20 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
104 |
91 |
$2K |
| 99408 |
|
112 |
105 |
$2K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
325 |
291 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
107 |
100 |
$1K |
| 96127 |
|
349 |
311 |
$947.60 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
16 |
13 |
$857.69 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
41 |
30 |
$781.36 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
26 |
24 |
$619.32 |
| 99473 |
|
148 |
123 |
$602.19 |
| G2025 |
Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only |
31 |
26 |
$532.91 |
| G0396 |
Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes |
42 |
35 |
$496.17 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
41 |
33 |
$492.63 |
| 99490 |
Ccm add 20min |
68 |
59 |
$477.41 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
250 |
216 |
$441.66 |
| 93000 |
|
25 |
22 |
$377.23 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
14 |
13 |
$375.58 |
| 99406 |
|
15 |
13 |
$140.81 |
| 3074F |
|
212 |
187 |
$140.00 |
| 3079F |
|
159 |
138 |
$120.00 |
| 81025 |
|
17 |
12 |
$88.66 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
159 |
142 |
$72.23 |
| 99173 |
|
41 |
30 |
$58.08 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
15 |
12 |
$28.56 |
| 3078F |
|
19 |
16 |
$10.00 |
| G9286 |
Antibiotic regimen prescribed within 10 days after onset of symptoms |
50 |
43 |
$0.00 |
| G9584 |
Patient evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soapp-r) or patient interviewed at least once during opioid therapy |
89 |
85 |
$0.00 |